TY - JOUR AU - Berhan, Asres AU - Barker, Alex PY - 2013 DA - 2013/12/17 TI - Sodium glucose co-transport 2 inhibitors in the treatment of type 2 diabetes mellitus: a meta-analysis of randomized double-blind controlled trials JO - BMC Endocrine Disorders SP - 58 VL - 13 IS - 1 AB - The discovery of sodium-glucose co-transporter 2 (SGLT2) inhibitors, with a novel mechanism independent of insulin secretion or sensitization, bring about a new therapeutic approach to the management of type 2 diabetes mellitus. The aim of this meta-analysis was to evaluate the safety and efficacy of SGLT2 inhibitors at different doses in randomized double blind clinical trials. SN - 1472-6823 UR - https://doi.org/10.1186/1472-6823-13-58 DO - 10.1186/1472-6823-13-58 ID - Berhan2013 ER -